Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › flucloxacillin

flucloxacillin

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of flucloxacillin

2 trials tracked of flucloxacillin: 1 in phase 3 or 4.

2Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 1
  1. Phase 3 Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA Completed
  2. Phase 2 Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Cefazolin shows potential for reduced acute kidney injury in patients with MSSA bacteremia
Infectious Disease RCT
Cefazolin shows potential for reduced acute kidney injury in patients with MSSA bacteremia Cefazolin Shows Potential for Treating MSSA Bacteremia in Adults
This review evaluated intravenous cefazolin compared to other antistaphylococcal penicillins for treating adults with MSSA bacteremia. The a…
Cefazolin may offer a safer option for treating certain blood infections, showing a lower risk of kidney issues in a recent review of clinic…
medRxiv Oct 14, 2026
HLA-B*57:01-guided abacavir prescribing is the clearest preventive paradigm from HLA associations
Drug Pipeline Sys. Review
HLA-B*57:01-guided abacavir prescribing is the clearest preventive paradigm from HLA associations HLA genes shape HIV and hepatitis vaccine responses and drug reactions
This narrative review examines HLA polymorphisms in HIV, hepatitis C, and hepatitis B. The clearest preventive paradigm is HLA-B*57:01-guide…
A review finds that HLA genes strongly influence how people respond to HIV and hepatitis vaccines and how they react to certain medications.
Frontiers Jun 6, 2026